Price
$5.72
Decreased by -5.45%
Dollar volume (20D)
1.34 M
ADR%
9.02
Earnings report date
Aug 25, 2025
Shares float
551.73 K
Shares short
93.72 K [16.99%]
Shares outstanding
2.28 M
Market cap
13.79 M
Beta
0.67
Price/earnings
N/A
20D range
5.23 6.84
50D range
5.23 10.94
200D range
2.95 15.82

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products.

Its product pipeline comprises PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; and PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors.

The company also develops PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials.

Portage Biotech Inc. is based in Tortola, British Virgin Islands.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 26, 24 -1.26
Decreased by -335.83%
-
Aug 14, 24 -1.26
Decreased by -281.21%
-
Jun 6, 24 -24.20
Decreased by -351.49%
-0.22
Decreased by -10.90 K%
Feb 28, 24 0.01
Increased by +102.27%
-0.27
Increased by +103.70%
Nov 28, 23 -0.29
Decreased by -383.33%
-0.28
Decreased by -3.57%
Aug 30, 23 -0.33
Decreased by -153.85%
-0.24
Decreased by -37.50%
May 31, 23 -5.36
Decreased by -857.14%
-0.29
Decreased by -1.75 K%
Mar 1, 23 -0.44
Decreased by -69.23%
-0.23
Decreased by -91.30%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 24 0.00
Decreased by N/A%
-1.36 M
Increased by +73.63%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-1.66 M
Increased by +72.02%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-24.89 M
Increased by +73.65%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 0.00
Decreased by N/A%
-39.37 M
Decreased by -424.90%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-5.16 M
Decreased by -375.39%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-5.92 M
Decreased by -264.25%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-94.45 M
Decreased by -965.64%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by N/A%
-7.50 M
Decreased by -113.58%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY